Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Shares Up 1.8% - Here's Why - Markets Daily

AbbVie Inc. $ABBV Stock Holdings Boosted by PNC Financial Services Group Inc. - Markets Daily

Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV

HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV

GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV

Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV

2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off - AOL

WJ Financial Advisors LLC Makes New $557,000 Investment in AbbVie Inc. $ABBV - Markets Daily

Is It Too Late To Consider AbbVie (ABBV) After Its Strong Multi‑Year Share Price Run?

AbbVie Inc. $ABBV Shares Acquired by BTC Capital Management Inc. - Markets Daily

DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV

CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis

AbbVie (NYSE:ABBV) Trading 1.8% Higher - Time to Buy?

AbbVie (NYSE:ABBV) Stock Price Up 1.8% - Here's What Happened - Stock Observer

Where is AbbVie Inc. (ABBV) Headed According to the Street?

Metis Global Partners LLC Has $22.53 Million Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Public Sector Pension Investment Board

Aldeyra's Dry Eye Therapy Faces FDA In March - Will The Third Time Be A Charm?

Freemont Management S.A. Trims Stake in AbbVie Inc. $ABBV

Capital Investment Counsel LLC Sells 2,482 Shares of AbbVie Inc. $ABBV - Daily Political

Pharmaceutical Stocks To Watch Today - February 12th - Stock Observer

Savvy Advisors Inc. Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. (ABBV) Achieves Record Net Sales on Diversified Growth Platform

Atria Investments Inc Decreases Stake in AbbVie Inc. $ABBV

Varma Mutual Pension Insurance Co Has $61 Million Stake in AbbVie Inc. $ABBV - Daily Political

Abbvie claims CMS' selection of Botox violates the IRA | BioWorld

Evercore ISI Cuts AbbVie Inc. (ABBV) PT, Says Consensus for 2026 and 2027 Still Looks Beatable

AbbVie Sues HHS Over Selection of Botox for Medicare Price Cuts

Abbvie sues US health agency over Botox

Dermal Fillers Market Forecast 2026-2036: Global Revenue to Reach USD 9.9 Billion by 2036 at 3.2%

ING Groep NV Purchases 528,196 Shares of AbbVie Inc. $ABBV - Markets Daily

Cibc World Market Inc. Acquires 60,635 Shares of AbbVie Inc. $ABBV

Rhumbline Advisers Decreases Stock Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie Reshapes U.S. Operations With Medicaid Concessions And Growth Focus

Top Pharmaceutical Stocks To Consider - February 10th - Markets Daily

AbbVie Inc. $ABBV Shares Sold by SVB Wealth LLC

Gilead Sciences News | Markets Insider

OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmology

Conducting Phase 3 Enabling Activities, Including Discussion

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 | Morningstar

How Recent Analyst Shifts Are Reframing AbbVie (ABBV) And Its Valuation Story

AbbVie, Astra Lose Appeal Over Louisiana Contract Pharmacy Law

ProShare Advisors LLC Lowers Holdings in AbbVie Inc. $ABBV

Candriam S.C.A. Has $193.50 Million Holdings in AbbVie Inc. $ABBV

Oppenheimer & Co. Inc. Acquires 5,688 Shares of AbbVie Inc. $ABBV

3 Market-Beating Stocks to Research Further

Candriam S.C.A. Has $193.50 Million Position in AbbVie Inc. $ABBV - Daily Political

Prognostic impact of myelodysplasia-related gene mutations in FLT3 -ITD-mutated acute myeloid leukemia

AbbVie Inc. $ABBV Shares Sold by Alps Advisors Inc.

Smartleaf Asset Management LLC Raises Holdings in AbbVie Inc. $ABBV - Stock Observer

ABBV: Future Returns Will Depend On Immunology Pipeline Clarity And M&A Uncertainty

a16z Perennial Management L.P. Takes $581,000 Position in AbbVie Inc. $ABBV - Markets Daily

Renaissance Group LLC Has $36.57 Million Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by State of Michigan Retirement System - Stock Observer

AbbVie Inc. $ABBV Position Decreased by Twin Capital Management Inc. - Stock Observer

AbbVie Q4 Earnings Call Highlights - Daily Political

AbbVie (NYSE:ABBV) Trading 2% Higher Following Analyst Upgrade

AbbVie (ABBV) One Off US$5.0b Loss Tests Bullish High P/E Valuation Narratives

Prime Capital Investment Advisors LLC Buys 3,759 Shares of AbbVie Inc. $ABBV - Markets Daily

Machina Capital S.A.S. Has $356,000 Holdings in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Stock Observer

Top Medical Stocks To Add to Your Watchlist - February 4th - Stock Observer

AbbVie's Prognosis: The February Dip Looks Like a Buy Signal | Investing.com

Best Pharmaceutical Stocks To Watch Today - February 5th - Stock Observer

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript

AbbVie Inc. $ABBV Shares Purchased by Howe & Rusling Inc. - Markets Daily

AbbVie Inc. $ABBV Shares Bought by ABN AMRO Bank N.V.

AbbVie Inc. $ABBV Stock Position Reduced by Homestead Advisers Corp

HORAN Wealth LLC Boosts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Bessemer Group Inc.

AbbVie (NYSE:ABBV) Price Target Raised to $270.00 - Stock Observer

AbbVie Earnings: Skyrizi Holds Steady Share Despite Competition | Morningstar Canada

AbbVie Q4 Earnings Call Highlights | MarketBeat

Triglav Investments D.O.O. Purchases 28,700 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (NYSE:ABBV) Shares Down 3.8% - Here's What Happened

AbbVie Inc (ABBV) Q4 2025 Earnings Call Highlights: Record Revenues and Strategic Growth Plans

AbbVie (NYSE:ABBV) Issues Q1 2026 Earnings Guidance - Stock Observer

AbbVie (NYSE:ABBV) Announces Earnings Results, Misses Estimates By $0.66 EPS

AbbVie (NYSE:ABBV) Shares Gap Down After Earnings Miss

AbbVie (ABBV) Stock: Why Shares Are Falling Despite Earnings Beat and Strong 2026 Guidance

AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial R

AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs

AlphaQuest LLC Trims Stock Position in AbbVie Inc. $ABBV

AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance - Daily Political

Savant Capital LLC Has $42.96 Million Holdings in AbbVie Inc. $ABBV

AbbVie Guides FY26 Adj. EPS Above Estimates; Q4 Results Top Estimates

AbbVie Q4 25 Earnings Conference Call At 9:00 AM ET

AbbVie News | Markets Insider

Envestnet Asset Management Inc. Reduces Position in AbbVie Inc. $ABBV - Daily Political

Savant Capital LLC Purchases 13,839 Shares of AbbVie Inc. $ABBV - Daily Political

Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation

Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?

Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?

XLM Stellar Price Prediction: How High Can XLM/USD Go in 2026?

Alphabet (GOOG) stock is trading down: What’s happening with Alphabet Inc.?

Gold price forecast: XAU/USD remains under $5000, what’s next?

Investment for beginners 2026: Is now a good time to buy Vanguard S&P 500 ETF?

NIO stock is trading down today: What’s happening with Nio Inc?

CFD Trading & Markets: Which CFD trading apps are best for beginners in 2026?

Nvidia Stock Analysis: Is now a good time to buy the dip in NVDA stock?

Tata Gold analysis: How does Tata Gold ETF compare to Tata Gold share?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift